Eurofins Scientific Acquires Majority Stake in LifeCodexx

July 27, 2017

Eurofins Scientific has acquired a 62.63% stake in LifeCodexx AG from GATC Biotech AG, strengthening Eurofins' non-invasive prenatal testing (NIPT) capabilities. LifeCodexx, headquartered in Constance, Germany, is a developer of the PrenaTest NIPT and generated approximately EUR 7m in revenue in 2016.

Buyers
Eurofins Scientific SE
Targets
LifeCodexx AG
Sellers
GATC Biotech AG
Industry
Biotechnology
Location
Baden-Württemberg, Germany
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.